Clinical Trial Update: Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of fostamatinib taken twice daily on blood pressure in patients with rheumatoid arthritis; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Fostamatinib (fostamatinib)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-04-14